Clinical research over the last few years has found that psychedelic drugs have the potential to treat mental health conditions, with many states having introduced legislation to enable psychedelic care. Three new bills were recently introduced.

Hawaii Senate Bill 967 would require Medicaid and private insurance to cover a portion of intravenous ketamine therapy costs for depression in qualified patients under licensed medical supervision, starting January 1, 2026.

Missouri House Bill 1043 would establish stricter guidelines for ordering and administering ketamine for mental health, including physician supervision requirements and mandatory documented treatment plans.

Texas House Bill 720 proposes a grant program for ketamine clinics to provide mental health treatment for active-duty military, first responders, and veterans, covering costs for uncompensated care and necessary services. This bill would require a report to be delivered by December 1st of every even-numbered year regarding the activities of the program and grant recipients, including results and outcomes.